All Events

Disruption and Innovation in Otology and Neurotology

Topics discussed include how the Endoscope has changed pediatric chronic ear surgery and new technology in ear surgery.

Disruption and Innovation in Otology and Neurotology

Three expert lectures (with Q&A).

This webinar took place on November 5, 2022.

Download your customizable Certificate of Attendance.

TOPICS FOR DISCUSSION:
  • How the Endoscope has Changed Pediatric Chronic Ear Surgery
  • New Technology in Ear Surgery
  • The Next Frontier: Exoscopes for Otology and Neurotology
Distinguished Speakers Include:
  • Sharon Cushing, MD, MSc
    Pediatric Otolaryngologist; Director of the Cochlear Implant Program, The Hospital for Sick Children; Associate Professor, Department of Otolaryngology-Head & Neck Surgery / University of Toronto / Canada
  • Seiji Kakehata, MD, PhD
    Professor and Chair, Department of Otolaryngology-Head and Neck Surgery, Faculty of Medicine / Yamagata University / Japan
  • Daniel J. Lee, MD, FACS
    Director, Pediatric Otology and Neurotology, Program Director, Harvard Neurotology Fellowship, Associate Professor, Department of Otology and Laryngology, Massachusetts Eye and Ear Infirmary / Harvard Medical School / United States

Moderators:

  • Alicia M. Quesnel, MD
    Otology, Neurotology, and Skull Base Surgery, Attending Surgeon, Massachusetts Eye and Ear; Director, Mass. Eye and Ear Otopathology Laboratory; Assistant Professor, Department of Otolaryngology-Head and Neck Surgery, Harvard Medical School; Clinical Associate / Massachusetts General Hospital / United States
  • Muaaz Tarabichi, MD
    AAO-HNSF International Advisory Board, Immediate Past Chair; Co-Founder / Tarabichi Stammberger Ear and Sinus Institute / United Arab Emirates
When
Add to your Calendar
Where

Virtual

Contact
No External Use or Transfer (Including AI-Based Technologies): The materials and content on this website are provided for personal, non-commercial transitory viewing only. You are prohibited from copying or transferring any materials or content accessed through this website into applications, software, bots, or websites which may allow third parties to retain or use the content, including but not limited to those using artificial intelligence-based technologies or infrastructure. Please see the Terms of Use for more information.